Mbathio Dieng1, Rachael L Morton2,3. 1. NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia. mbathio.dieng@sydney.edu.au. 2. NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia. 3. Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Authors: Mbathio Dieng; Sarah J Lord; Omgo E Nieweg; Robyn P M Saw; Andrew J Einstein; Amanda A G Nijhuis; Robin M Turner; John F Thompson; Rachael L Morton Journal: Ann Surg Oncol Date: 2021-05-02 Impact factor: 5.344